Shivering Clinical Trial
Official title:
Prophylactic Paracetamol or Dexamethasone for Post-spinal Anesthesia Shivering in Patients Undergoing Non-obstetric Surgeries: a Randomized Controlled Trial
This study was conducted to evaluate the effects of a prophylactic dose of oral paracetamol on shivering compared with prophylactic intravenous infusion (IVI) dexamethasone in patients undergoing non-obstetric surgeries under spinal anesthesia.
Enrollment After approval by the institute ethics committee, this study was conducted at
Ain-Shams university hospitals, from the1st of March 2018 till the 31st of August 2018, on
300 patients aged 18-60 years and body weight 60-100 Kg of the American Society of
Anesthesiologists (ASA) physical status I or II who underwent non-obstetric surgeries under
spinal anesthesia were enrolled in this study.
Patient`s refusal, duration of surgery more than 120 min, obesity with body mass index (BMI)
>35 kg/m2, generalized infection or localized infection at level of blockade, neurologic
disease, coagulation disorder, patients with hypo- or hyperthyroidism, cardiopulmonary
disease, psychological disorders, a need for blood transfusion during surgery, an initial
body temperature >38.0C or <36.0C, a known history of alcohol or substance abuse, or
receiving vasodilators, or medications likely to alter thermoregulation excluded the patient.
from the study Randomization and Blinding This study was designed to be a randomized,
placebo-controlled, double-blinded parallel study. Following enrollment, patients were
randomized into 3 equal groups;
1. The P (Paracetamol) group:(n=100) each patient received 1g paracetamol tablet orally
with sips of water and 100 ml 0.9% sodium chloride (normal saline [NS]) (IVI) over 15
minutes as a placebo for Dex solution 2 hours preoperatively.
2. The D (Dexamethasone) group: (n=100) each patient received a placebo tablet identical to
paracetamol tablet orally with sips of water and Dex 8 mg ampoule diluted in 100 ml 0.9%
NS IVI over 15 minutes, 2 hours preoperatively.
3. The C (Control) group: (n=100) each patient received a placebo tablet identical to
paracetamol tablet orally with sips of water and 100 ml 0.9% NS IVI over 15 minutes as a
placebo for Dex solution 2 hours preoperatively.
Randomization was done using computer-generated table of random numbers in a 1:1 ratio in
opaque and sealed envelope (SNOSE). The assigned treatment was written on a card and sealed
in opaque envelopes consecutively numbered. These envelopes were opened just immediately
before infusing the medication in the patient's room. The study drugs were prepared by the
hospital pharmacy and follow-up of patients were conducted by anesthesia residents not
involved in any other part of the study.
Study Protocol On arrival in the operating theatre, all patients had an inserted venous
cannula. I.V. fluids were preheated to 37oC. No other warming device was used. Lactated
Ringer's solution was warmed to 37 oC and was infused at 10 ml/kg over 30 min before spinal
anesthesia. The infusion rate was reduced to 6 ml/ kg.
Subarachnoid anesthesia was instituted at either L3/4 or L4/5 interspaces. Hyperbaric
bupivacaine, 5 mg /ml, 15 mg was injected using a 25 G Quincke spinal needle.
Supplemental oxygen (5 liter/ min) was delivered via a facemask during the operation. All
patients were covered with one layer of surgical drapes over the chest, thighs, and calves
during the operation and one cotton blanket over the entire body after operation. The
operating and recovery rooms temperatures were maintained at 23-25°C with approximately 60%
humidity.
Assessment parameters Heart rate, mean arterial pressure (MAP), and peripheral oxygen
saturation were recorded using standard noninvasive monitors before intrathecal injection and
thereafter at 5, 10, 15, 20 minutes then every 10 minutes to complete 90 minutes from the
intrathecal injection.
Sensory levels were assessed by pinprick to determine the peak sensory level and time to two
segment regression in minutes. Motor block was assessed by using Modified Bromage scale(16)
(0 = no block 1 = hip block, 2 = hip and knee block, 3 = hip, knee, and ankle block) to
determine the time to reach complete motor block and duration of motor blockade (minutes).
Sedation score was assessed with a four-point scale as per Filos et al.(17): 1: Awake and
alert. 2: Somnolent, but responsive to verbal stimuli. 3: Somnolent, arousable to physical
stimuli. 4: Unarousable.
Body temperature (axillary temperature) was recorded with an axillary thermometer. The
ambient temperature was measured by a wall thermometer. The ambient temperature was
maintained at 25oC with constant humidity.
Shivering if occurred was graded using a scale similar to that validated by Badjatia et al
(18):
1. None: no shivering noted on palpation of the masseter, neck, or chest wall
2. Mild: shivering localized to the neck and/or thorax only
3. Moderate: shivering involved gross movement of the upper extremities (in addition to
neck and thorax)
4. Severe: shivering involved gross movements of the trunk and upper and lower extremities.
Shivering was assessed immediately before the block and every 10 minutes till the end of
surgery and for another 20 min in the recovery room. Grade 3 or 4 of shivering score was
regarded failure of prophylaxis, meperidine 25 mg IV was administered and no assessment of
shivering was done.
Side-effects, including hypotension (defined as a decrease in MAP of more than 20% from
baseline or a decrease of arterial blood pressure below 90 mmHg and baseline MAP was
calculated from three measurements taken on the ward before surgery) was treated by
crystalloid infusion and if necessary ephedrine 5 mg IV was administered. The amount of
ephedrine given in each group was recorded. Bradycardia was considered if the heart rate <50
beats/min and was treated with IV atropine (0.01mg/kg). If there was respiratory depression
(RR < 12 bpm) and a decrease in arterial SpO2 (<90%), it was treated with oxygen through a
transparent face mask. Incidence of nausea and vomiting during early 2 hours postoperatively
were recorded. IV granisetron (1 mg) was given in case of vomiting or after 2 successive
episodes of nausea.
Patient`s satisfaction was done by asking the patient to answer the question, "How would you
rate your experience after the surgery?" using a 7‑point Likert verbal rating scale(19):
[Figure 1] and acceptable satisfaction score of the patient being 5-7.
Likert scale:
1 2 3 4 5 6 7 Extremely dissatisfied Dissatisfied Somewhat dissatisfied Undecided Somewhat
satisfied Satisfied Extremely satisfied Figure 1: A 7‑point Likert‑like verbal rating scale
for assessment of patients` satisfaction(19).
Endpoint: The study end point was 20 minutes after the end of the procedure (in the recovery
room)
Primary Outcome Measure:
Total participants received pethidine for treatment of post-spinal shivering in the three
groups till 20 minutes after the end of the procedure (in the recovery room)
Secondary Outcome Measures:
- Incidence, onset, severity and duration of post-spinal shivering.
- Time to first analgesic request, from the end of surgery up to approximately six hours
after surgery
- Incidence of hypotension.
- Incidence of bradycardia.
- Incidence of nausea and vomiting during early 2 hours postoperatively.
- Patient' satisfaction towards shivering prophylaxis was assessed 24 hours after the
procedure.
3-Analysis of Data:
Depending on Gholami et al., 2016 who found that shivering was 18% and 64.0% in paracetamol
and control respectively(20) and on El Bakry et al., 2016 who found that shivering was 20.0%
and 50.0% in dexamethasone and control respectively(21) and assuming the power= 0.80 and
α=0.05, and by using PASS 11th release the minimal sample size for an equal controlled study
to detect a significant statistical difference between paracetamol & dexamethasone and
control was 80 women in each group. We recruited 100 women in each group for possible
attrition(22).
The collected data were coded, tabulated, and statistically analyzed using IBM SPSS
statistics (Statistical Package for Social Sciences) software version 22.0, IBM Corp.,
Chicago, USA, 2013.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04730609 -
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
|
Phase 4 | |
Completed |
NCT02141412 -
Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia
|
Phase 4 | |
Not yet recruiting |
NCT06283771 -
The Effect of Heated Socks Developed With Wearable Technology on Hypothermia, Thermal Comfort Perception and Shivering
|
N/A | |
Completed |
NCT02436174 -
Assessment Of Shivering With iSeismograph
|
N/A | |
Completed |
NCT03302351 -
Dexmedetomidine, Ketamine and Dexmetedomidine-Ketamine Combination for Control of Shivering During Regional Anaethesia
|
Phase 4 | |
Completed |
NCT03721432 -
The Effect of Oral Pregabalin on Epidural-induced Shivering and Epidural Characteristics
|
N/A | |
Not yet recruiting |
NCT03530007 -
Anti-shivering Effect of Ondansetron
|
Phase 2/Phase 3 | |
Completed |
NCT03675555 -
Prophylactic Mirtazapine or Dexamethasone for Post-spinal Anesthesia Shivering
|
Phase 4 | |
Completed |
NCT03679052 -
Prophylactic Mirtazapine or Clonidine for Post-spinal Anesthesia Shivering
|
Phase 4 | |
Recruiting |
NCT04938219 -
Shivering_Basel_Baden
|
N/A | |
Active, not recruiting |
NCT05284409 -
Comparative Study Between the Prophylactic Intravenous Administrations of Acetaminophen vs Dexamethasone vs Pethidine Regarding the Incidence of Shivering Induced by Single Shot Spinal Anesthesia in the Orthopedic Surgeries of the Lower Limbs
|
Phase 4 | |
Recruiting |
NCT03157648 -
Relationship Between Core-peripheral Temperature Difference and Shivering Symptom in Patients in PACU
|
N/A | |
Terminated |
NCT03497507 -
Investigating the Effect of Acupressure on Shivering During a Cesarean Delivery in Women Who Were Previously Laboring With an Epidural
|
N/A | |
Completed |
NCT03370562 -
Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering
|
N/A | |
Completed |
NCT05110469 -
Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia
|
Phase 4 | |
Not yet recruiting |
NCT03566628 -
Post-anaesthetic Shivering Amongst Patients Undergoing Cerebral Angiography
|
N/A | |
Completed |
NCT02967601 -
Influence of Preoperative Anxiety on Shivering During Elective Caesarean Section Under Spinal Anaesthesia
|
N/A | |
Recruiting |
NCT05765162 -
Safe Brain Initiative, Operationalizing Precision Anaesthesia
|
||
Recruiting |
NCT04870541 -
Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.
|
Phase 4 | |
Active, not recruiting |
NCT01669213 -
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension
|
N/A |